Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOSITION AND METHOD USING ANTI-CSI ANTIBODY FOR TREATING MULTIPLE MYELOMA
Document Type and Number:
Japanese Patent JP2014040421
Kind Code:
A
Abstract:

To provide a pharmaceutical composition for treatment of multiple myeloma.

A pharmaceutical composition for treatment of multiple myeloma in a subject comprises (a) HuLuc63 which is a humanized IgG1 antibody having a heavy chain variable region corresponding to sequence number 5 and a light chain variable region corresponding to sequence number 6 and (b) dexamethasone, where any other active ingredient is not administered to the subject. And a pharmaceutical composition comprises (a) HuLuc63 which is a humanized IgG1 antibody having a heavy chain variable region corresponding to sequence number 5 and a light chain variable region corresponding to sequence number 6, (b) dexamethasone and (c) thalidomide, where any other active ingredient is not administered to the subject.


Inventors:
AFAR DANIEL
Application Number:
JP2013178996A
Publication Date:
March 06, 2014
Filing Date:
August 30, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AVVI BIOTHERAPEUTICS INC
International Classes:
A61K39/395; A61K31/454; A61K31/573; A61K33/243; A61P7/00; A61P35/00; A61P43/00
Domestic Patent References:
JP5340935B22013-11-13
JP5340935B22013-11-13
Foreign References:
US20060024296A12006-02-02
US20060024296A12006-02-02
Other References:
JPN6012047163; J.Clin.Oncol., 2006.1.20, Vol. 24, No. 3, P. 431-436
JPN6012047163; J.Clin.Oncol., 2006.1.20, Vol. 24, No. 3, P. 431-436
Attorney, Agent or Firm:
Kawaguchi International Patent Office